Home/Filings/4/0001209191-14-005406
4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-005406

CIK 0001009356operating

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 9:52 PM ET

Size

10.0 KB

Accession

0001209191-14-005406

Insider Transaction Report

Form 4
Period: 2014-01-24
Transactions
  • Gift

    Common Stock

    2014-01-2410,45087,524 total
  • Gift

    Common Stock

    2014-01-24+10,45010,450 total(indirect: By Trust)
Holdings
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: By LP)
    260
  • Common Stock

    (indirect: By Spouse)
    6,500
  • Common Stock

    (indirect: By Trust)
    1,080
Footnotes (3)
  • [F1]The shares are held by the Thomas W. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  • [F2]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  • [F3]Options are 100% vested.

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001009356

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:52 PM ET
Size
10.0 KB